Who Paid My Doc Search
Menu
Product Program year 2019 Source: CMS Open Payments

Daraprim 30 Tablet in 1 Bottle

Drug Toxoplasmosis

NDC 69413-330-30

Open in the dashboard

General payments

$10,534

613 payments

Research payments

$8,300

1 payment

Through program year 2019, $10,534 in general payments and $8,300 in research payments were reported against Daraprim 30 Tablet in 1 Bottle (Toxoplasmosis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $10,534 613
2019 Research $8,300 1

Breakdown

Who paid General payments · program year 2019
  1. Vyera Pharmaceuticals, LLC $10,534 613 payments
Top recipients General payments · program year 2019
  1. Stephen Threlkeld Infectious Disease · Memphis, TN $93 <1% · 5 payments
  2. Indulekha Gopal Infectious Disease · Coral Springs, FL $66 <1% · 3 payments
  3. Ramprasad Gopalan Infectious Disease · Boynton Beach, FL $65 <1% · 3 payments
  4. Kevin Merigian General Practice · Eads, TN $63 <1% · 2 payments
  5. Shannon Tyler Infectious Disease · Mobile, AL $63 <1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Infectious Disease Internal Medicine $3,237 31% · 143 practitioners
  2. Internal Medicine $2,070 20% · 103 practitioners
  3. Family Medicine $1,524 15% · 80 practitioners
  4. Ophthalmology $676 6% · 41 practitioners
  5. Retina Specialist Ophthalmology $481 5% · 27 practitioners

The top 5 of 51 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. California $1,092 10% · 53 recipients
  2. Pennsylvania $1,029 10% · 56 recipients
  3. Illinois $924 9% · 47 recipients
  4. Tennessee $883 8% · 38 recipients
  5. Florida $705 7% · 27 recipients

The top 5 of 39 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

Records

613 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record